According to their work PIK3CA was the second most common type of mutation with a frequency of >10% in majority of the cancers except ovarian serous carcinoma, renal clear cell cancer, lung adenocarcinoma and acute myeloid leukemia. The gene discussed is PIK3CA; the disease is lung adenocarcinoma.